Transforming growth factors (TGFs): Properties and possible mechanisms of action
✍ Scribed by Todaro, George J. ;De Larco, Joseph E. ;Fryling, Charlotte ;Johnson, Patricia A. ;Sporn, Michael B.
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 1981
- Tongue
- English
- Weight
- 1011 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0275-3723
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Transforming growth factors (TGFs) are growth‐promoting polypeptides that cause phenotypic transformation and anchorage‐independent growth of normal cells. They have been isolated from several human and animal carcinoma and sarcoma cells. One TGF is sarcoma growth factor (SGF) which is released hy murine sarcoma virus‐transformed cells. The TGFs interact with epidermal growth factor (EGF) cell membrane receptors. TGFs are not detectable in culture fluids from cells which contain high numbers of free EGF cell membrane receptors. SGF acts as a tumor promoter in cell culture systems and its effect on the transformed phenotype is blocked by retinoids (vitamin A and synthetic analogs). The production of TGFs by transformed cells and the responses of normal cells to the addition of TGFs to the culture medium raise the possibility that cells “autostimulate” their own growth by releasing factors that rebind at the cell surface. The term “autocrine secretion” has been proposed for this type of situation where a cell secretes a hormone‐like substance for which it has external cell membrane receptors. The autocrine concept may provide a partial explanation for some aspects of tumor cell progression.
📜 SIMILAR VOLUMES
Publication of the International Union Against Cancer Publication de I'Union lnternationale Contre le Cancer
Transforming growth factor-beta (TGF-P) is a polypeptide with multiple physiological functions. lsoforms of this growth factor have important roles in control of the cell cycle, in regulation of cell-cell interactions and in growth and development. Malignant transformation has been shown to be assoc
Various osteoblastic cell lines were examined for the relationship between the presence of cell-surface transforming growth factor (TGF)-P receptors and the synthesis of matrix proteins with their responsiveness to TGF-P. Treatment with TGF-PI inhibited proliferation and stimulated proteoglycan and